Literature DB >> 19118466

Double-j stenting compared with one night externalized ureteral catheter placement in tubeless percutaneous nephrolithotomy.

Murat Gonen1, Bulent Ozturk, Hakan Ozkardes.   

Abstract

PURPOSE: We prospectively analyzed the outcome of tubeless percutaneous nephrolithotomies (PCNLs) using two different stenting techniques (i.e., externalized ureteral catheter compared with Double-J placement) without strict exclusion or inclusion criteria. PATIENTS AND METHODS: Forty-six patients who were undergoing tubeless PCNL were randomized to two groups: Group 1 (tubeless PCNL with externalized ureteral catheter) and group 2 (tubeless PCNL with Double-J placement). The only exclusion criterion was presence of significant residual stones. The two groups were comparable with regard to age, sex, stone laterality, stone burden, and number of previous open renal surgeries. Factors evaluated included operative time, stent-related symptoms, analgesic requirement, postoperative pain, postoperative morbidity, hospital stay, blood loss, and success rates.
RESULTS: The mean operative times, mean number of accesses, percentage of supracostal accesses, mean visual analog scale scores, analgesic requirements, mean decreases in hemoglobin level, blood transfusion rates, success rates, and mean hospital stays were not statistically significant in both groups. The only statistically significant difference between groups was the postoperative stent-related symptoms. In group 2, 52.1% experienced some sort of stent-related symptoms. In most of the patients, these symptoms were not severe; however, in two of them (16.6 %), oral medication therapy with anticholinergics was needed. None of the patients in group 1 had stent-related symptoms and needed medication (P < 0.01).
CONCLUSIONS: Tubeless PCNL with externalized ureteral catheter is as feasible as Double-J stenting. Moreover, stent-related discomforts because of the presence of a Double-J stent and the need for postoperative cystoscopy to remove the Double-J stent can be avoided with an externalized ureteral catheter.

Entities:  

Mesh:

Year:  2009        PMID: 19118466     DOI: 10.1089/end.2008.0382

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  6 in total

1.  Immediate postoperative morbidity in patients with indwelling double-J stent versus overnight-externalized ureteral catheter after tubeless percutaneous nephrolithotomy: a prospective, randomized study.

Authors:  Alejandro Mercado; Mario I Fernández; Pedro Recabal; Daniela Fleck; Rodrigo Ledezma; Francisco Moya; Francisco Sepúlveda; Roberto Vilches; Diego Reyes; Fernando Marchant
Journal:  Urolithiasis       Date:  2013-03-23       Impact factor: 3.436

2.  Simultaneous bilateral tubeless percutaneous nephrolithotomy of staghorn stones: a prospective randomized controlled study.

Authors:  Chung-Jing Wang; Chien-Hsing Chang; Shi-Wei Huang
Journal:  Urol Res       Date:  2010-12-16

3.  Tubeless percutaneous nephrolithotomy.

Authors:  Madhu Sudan Agrawal; Mayank Agrawal
Journal:  Indian J Urol       Date:  2010 Jan-Mar

4.  Exit strategies following percutaneous nephrolithotomy (PCNL): a comparison of surgical outcomes in the Clinical Research Office of the Endourological Society (CROES) PCNL Global Study.

Authors:  Luigi Cormio; Gaspar Ibarlucea Gonzalez; David Tolley; Mario Sofer; Ahmet Muslumanoglu; Hans-Christoph Klingler; Jens-Uwe Stolzenburg; Jean de la Rosette
Journal:  World J Urol       Date:  2012-07-01       Impact factor: 4.226

5.  Comparative Study of Externalized Ureteral Catheter Versus Double-J Stent on Percutaneous Nephrolithotomy: A Randomized Controlled Trial.

Authors:  Bilal Habib; Sadiqa Hassan; Mohammad Roman; Khursheed Anwar; Amber Latif
Journal:  Cureus       Date:  2022-03-08

6.  Hemostatic agents for access tract in tubeless percutaneous nephrolithotomy: Is it worth?

Authors:  Francisco Sepulveda; Alfredo Aliaga; Daniela Fleck; Mario Fernandez; Alejandro Mercado; Roberto Vilches; Francisco Moya; Rodrigo Ledezma; Diego Reyes; Fernando Marchant
Journal:  Urol Ann       Date:  2016 Apr-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.